Viking Therapeutics (VKTX) Total Current Liabilities (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Total Current Liabilities came in at $109.7 million in Q2 2026, up 242.89% year-over-year from $32.0 million in Q2 2025, and up 3.13% quarter-over-quarter from $106.3 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Total Current Liabilities (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Total Current Liabilities across 13 years of filings, most recently posting $109.7 million for Q2 2026.
- In Q2 2026, Total Current Liabilities rose 242.89% year-over-year to $109.7 million; the TTM figure through Jun 2026 stood at $109.7 million (up 242.89% YoY), while the FY2025 annual figure was $76.7 million, up 179.67% from the prior year.
- Total Current Liabilities came in at $109.7 million for Q2 2026 at Viking Therapeutics, up from $106.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $109.7 million in Q2 2026 to a low of $11.3 million in Q1 2022.
- Average Total Current Liabilities over 5 years is $33.6 million, with a median of $23.5 million recorded in 2022.
- Year-over-year, Total Current Liabilities tumbled 40.28% in 2025 and surged 443.22% in 2026.
- Over 5 years, Total Current Liabilities stood at $21.9 million in 2022, then fell by 12.81% to $19.1 million in 2023, then jumped by 43.26% to $27.4 million in 2024, then surged by 179.67% to $76.7 million in 2025, then soared by 43.03% to $109.7 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $109.7 million in Q2 2026, $106.3 million in Q1 2026, and $76.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | 109.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 109.66 Mn |
| Mar 31, 2026 | 106.33 Mn |
| Dec 31, 2025 | 76.67 Mn |
| Sep 30, 2025 | 26.07 Mn |
| Jun 30, 2025 | 31.98 Mn |
| Mar 31, 2025 | 19.57 Mn |
| Dec 31, 2024 | 27.41 Mn |
| Sep 30, 2024 | 25.69 Mn |
| Jun 30, 2024 | 25.09 Mn |
| Mar 31, 2024 | 32.77 Mn |
| Dec 31, 2023 | 19.14 Mn |
| Sep 30, 2023 | 13.41 Mn |
| Jun 30, 2023 | 13.48 Mn |
| Mar 31, 2023 | 15.65 Mn |
| Dec 31, 2022 | 21.95 Mn |
| Sep 30, 2022 | 14.06 Mn |
| Jun 30, 2022 | 14.86 Mn |
| Mar 31, 2022 | 11.27 Mn |
| Dec 31, 2021 | 8.78 Mn |
| Sep 30, 2021 | 11.35 Mn |
API Access
Viking Therapeutics Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();